Broekhuizen, F. F., Utrie, J., Van Mullem, C. V. Drug use or inadequate prenatal care? Adverse pregnancy outcome in an urban setting. Am J Obstet Gynecol 1992; 166:1747–56.Google Scholar

Berenson, A. B., Wilkinson, G. S., Lopez, L. A. Effects of prenatal care on neonates born to drug-using women. Subst Use Misuse 1996; 31:1063–76.CrossRefGoogle ScholarPubMed

El-Mohandes, A., Herman, A. A., Nabil El-Khorazaty, M., et al. Prenatal care reduces the impact of illicit drug use on pernatal outcomes. J Perinatol 2003; 23:354–60.CrossRefGoogle Scholar

Finer, L. B., Henshaw, S. K. Disparities in rates of unintended pregnancy in the United States, 1994 and 2001. Perspect Sex Reprod Health 2006; 38:90–6.Google Scholar

Mohllajee, A. P., Curtis, K. M., Morrow, B., Marchbanks, P. A. Pregnancy intention and its relationship to birth and maternal outcomes. Obstet Gynecol 2007; 109:678–86.CrossRefGoogle ScholarPubMed

Heil, S. H., Jones, H. E., Arria, A., et al. Unintended pregnancy in opioid-abusing women. J Subst Abuse Treat 2011; 40:199–202.CrossRefGoogle ScholarPubMed

Santen, F. J., Sofsky, J., Bilic, N., Lippert, R. Mechanism of action of narcotics in the production of menstrual dysfunction in women. Fertil Steril 1975; 26:538–48.Google Scholar

Terplan, M., Hand, D. J., Hutchinson, M., Salisbury-Afshar, E., Heil, S. H. Contraceptive use and method choice among women with opioid and other substance use disorders: A systematic review. Prev Med 2015; 80:23–41.Google Scholar

Viguera, A. C., Whitfield, T., Baldessarini, R. J., et al. Risk of recurrence in women with bipolar disorder during pregnancy: Prospective study of mood stabilizer discontinuation. Am J Psychiatry 2007; 164:1817–24.CrossRefGoogle ScholarPubMed

Newport, D. J., Stowe, Z. N., Viguera, A. C., et al. Lamotrigine in bipolar disorder: Efficacy during pregnancy. Bipolar Disord 2008; 10:432–6.CrossRefGoogle ScholarPubMed

Martino, S. C., Collins, R. L., Ellickson, P. L., Klein, D. J. Exploring the link between substance use and abortion: The roles of unconventionality and unplanned pregnancy. Perspect Sex Reprod Health 2006; 38:66–75.Google Scholar

Schempf, A. Illicit drug use and neonatal outcomes: A critical review. Obstet Gynecol Surv 2007; 62:749–57.Google Scholar

Burns, L., Mattick, R. P., Wallace, C. Smoking patterns and outcomes in a population of pregnant women with other substance use disorders. Nicotine Tob Res 2008; 10:969–74.CrossRefGoogle Scholar

Cressman, A. M., Pupco, A., Kim, E., Koren, G., Bozzo, P. Smoking cessation therapy during pregnancy. Can Fam Physician 2012; 58:525–7.Google Scholar

Center for Substance Abuse Treatment. Medication-Assisted Treatment for Opioid Addiction During Pregnancy. In: SAMHSA/CSAT treatment improvement protocols, editors. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2008. Available at: www.ncbi.nlm.nih.gov/books/NBK64148. Accessed October 26, 2016.Google Scholar

Kaltenbach, K., Berghella, V., Finnegan, L. Opioid dependence during pregnancy. Effects and management. Obstet Gynecol Clin North Am, 1998; 25(1):139–51.Google Scholar

Whiteman, V. E., Salemi, J. L., Mogos, M. F., et al. Maternal opioid drug use during pregnancy and its impact on perinatal morbidity, mortality, and the costs of medical care in the United States. J Pregnancy 2014; 2014:Article ID 906723.Google Scholar

Binder, T., Vavrinková, B. Prospective randomised comparative study of the effect of buprenorphine, methadone and heroin on the course of pregnancy, birthweight of newborns, early postpartum adaptation and course of the neonatal abstinence syndrome (NAS) in women followed up in the outpatient department. Neuro Endocrinol Letters 2008; 29(1):80–6.Google ScholarPubMed

Reading, A., Campbell, S., Cox, D. N., Sledmere, C. M. Health beliefs and health care behavior in pregnancy. Psychol Med 1982; 12:379–83.Google Scholar

deJong-Pleij, E. A. P., Ribbert, L. S. M., Pistorius, L. R., et al. Three-dimensional ultrasound and maternal bonding, a third trimester study and a review. Prenat Diagn 2013; 33:81–8.Google Scholar

Zilberman, M. L., Tavares, H., Blume, S. B., el-Guebaly, N. Substance user disorder: Sex differences and psychiatric comorbidities. Can J Psychiatry 2003; 48:5–13.Google Scholar

Holbrook, A., Kaltenbach, K. Co-occurring psychiatric symptoms in opioid-dependent women: The prevalence of antenatal and postnatal depression. Am J Drug Alcohol Abuse 2012; 38:575–9.CrossRefGoogle ScholarPubMed

Coffey, R. M., Houchens, R., Chu, B. C., et al. Emergency Department Use for Mental and Substance Use Disorders. Online August 23, 2010, U.S. Agency for Healthcare Research and Quality (AHRQ). Available at: www.hcup-us.ahrq.gov/reports.jsp. Accessed December 4, 2017.Google Scholar

Wright, T. E., Schuetter, R., Fombone, E., Stephenson, J., Haning, W. F. Implementation and evaluation of a harm-reduction model for clinical care of substance using pregnant women. Harm Reduct J 2012; 9:5.Google Scholar

Macrory, F., Boyd, S. C. Developing primary and secondary services for drug and alcohol dependent mothers. Semin Fetal Neonatal Med 2007; 12:119–29.Google Scholar

Chavan, N., Ashford, K. B., Wiggins, A., Roberts, M., Critchfield, A. Perinatal assistance and treatment homes for opioid use disorders in pregnancy: Impact on perinatal outcomes. Am J Obstet Gynecol 2017; 216;S425–6.Google Scholar

Goler, N. C., Armstrong, M. A., Osejo, V. M., et al. Early start: A cost beneficial perinatal substance abuse program. Obstet Gynecol 2012; 119:102–10.CrossRefGoogle Scholar

Robins, L. N., Mills, J. L. Effects of in utero exposure to street drugs. Am J Pub Health 1993; 83(Suppl):2–32.Google Scholar

Center for Behavioral Health Statistics and Quality. 2014 National Survey on Drug Use and Health: Detailed Tables. Substance Abuse and Mental Health Services Administration, Rockville, MD, 2015.Google Scholar

Patrick, S. W., Schumacher, R. E., Benneyworth, B. D., et al. Neonatal abstinence syndrome and associated health care expenditures: United States, 2000-2009. JAMA 2012 May 9; 307(18):1934–40.Google Scholar

Substance Abuse and Mental Health Services Administration. A Collaborative Approach to the Treatment of Pregnant Women with Opioid Use Disorders. HHS Publication No. (SMA) 16-4978. Rockville, MD: Substance Abuse and Mental Health Services Administration, 2016. Available at: http://store.samhsa.gov/.Google Scholar

McLellan, T. A., Kuschner, H., Metzger, D., et al. The fifth edition of the Addiction Severity Index. J Subst Abuse Treat 1992; 9:199–213.CrossRefGoogle ScholarPubMed

Jones, H. E., O'Grady, K. E., Malfi, D., Tuten, M. Methadone maintenance vs. methadone taper during pregnancy: maternal and neonatal outcomes. Am J Addict 2008 Sep–Oct; 17(5);372–86.Google Scholar

Benningfield, M. M., Arria, A. M., Kaltenbach, K., et al. Co-occurring psychiatric symptoms are associated with increased psychological, social, and medical impairment in opioid dependent pregnant women. Am J Addict 2010; 19:416–21.CrossRefGoogle ScholarPubMed

Fitzsimons, H., Tuten, M., Vaidya, V., Jones, H. E. Mood disorders affect drug treatment success of drug-dependent pregnant women. J Subst Abuse Treat 2007; 32:19–25.Google Scholar

Jansson, L. M., Svikis, D., Lee, J., et al. Pregnancy and addiction. A comprehensive care model. J Subst Abuse Treat 1996 Jul–Aug; 13(4):321–9.CrossRefGoogle ScholarPubMed

Dennis, K., Young, N. K., Gardner, S. G. Funding Family-Centered Treatment for Women with Substance Use Disorders. Irvine, CA: Children and Family Futures Inc; 2008. Available at: www.samhsa.gov/sites/default/files/final_funding_paper_508v.pdfGoogle Scholar

Jones, H. E., Finnegan, L. P., Kaltenbach, K. Methadone and buprenorphine for the management of opioid dependence in pregnancy. Drugs 2012 Apr; 72(6):747–7.Google Scholar

Del Campo, E. J., John, D. S., Kauffman, C. C. Evaluation of the 21-day outpatient heroin detoxification. Int J Addict 1977 Oct; 12(7):923–35.Google Scholar

Banys, P., Tusel, D. J., Sees, K. L., Reilly, P. M., Delucchi, K. L. Low (40 mg) versus high (80 mg) dose methadone in a 180-day heroin detoxification program. J Subst Abuse Treat. 1994 May–Jun; 11(3):225–32.CrossRefGoogle Scholar

Amato, L., Davoli, M., Minozzi, S., et al. Methadone at tapered doses for the management of opioid withdrawal. Cochrane Database Syst Rev 2013 Feb 28; (2):CD003409.Google Scholar

Zuspan, F. P., Gumpel, J. A., Mejia-Zelaya, A., Madden, J., Davis, R. Fetal stress from methadone withdrawal. Am J Obstet Gynecol. 1975 May 1; 122(1):43–6.CrossRefGoogle ScholarPubMed

Rementeriá, J. L., Nunag, N. N. Narcotic withdrawal in pregnancy: Stillbirth incidence with a case report. Am J Obstet Gynecol. 1973 Aug 15; 116(8):1152–6.Google Scholar

Center for Substance Abuse Treatment. Detoxification and Substance Abuse Treatment. Treatment Improvement Protocol (TIP) Series 45. DHHS Publication No. (SMA) 06-4131. Rockville, MD: Substance Abuse and Mental Health Services Administration, 2006.Google Scholar

Jones, H. E., Terplan, M., Meyer, M. Medically assisted withdrawal (detoxification): Considering the mother-infant dyad. J Addict Med 2017, Mar/Apr;11(2):90–92.CrossRefGoogle ScholarPubMed

Drugs.com. Available at: www.drugs.com/pregnancy-categories.html. Retrieved January 27, 2017.Google Scholar

Jones, H. E., Deppen, K., Hudak, M. L., et al. Clinical care considerations for opioid-using pregnant and postpartum women: The role of obstetric providers. Am J Obstet Gynecol 2014 Apr; 210(4):302–10.Google Scholar

Zuspan, F. P., Gumpel, J. A., Mejia-Zelaya, A., Madden, J., Davis, R. Fetal stress from methadone withdrawal. Am J Obstet Gynecol 1975 May 1; 122(1):43–6.Google Scholar

National Institutes of Health. Effective medical treatment of opiate addiction. NIH Consens Statement 1997 Nov 17–19; 15(6):1–38.Google Scholar

Wiegand, S. L., Swortwood, M. J., Huestis, M. A., et al. Naloxone and metabolites quantification in cord blood of prenatally exposed newborns and correlations with maternal concentrations. AJP Rep 2016 Oct; 6(4):e385–e390.Google ScholarPubMed

Bailey, B. Are there teratogenic risks associated with antidotes used in the acute management of poisoned pregnant women? Birth Defects Res A Clin Mol Teratol. 2003 Feb; 67(2):133–40.CrossRefGoogle ScholarPubMed

Wiegand, S. L., Stringer, E. M., Stuebe, A. M., et al. Buprenorphine and naloxone compared with methadone treatment in pregnancy. Obstet Gynecol 2015 Feb; 125(2):363–8.Google Scholar

Jumah, N. A., Edwards, C., Balfour-Boehm, J., et al. Observational study of the safety of buprenorphine+naloxone in pregnancy in a rural and remote population. BMJ Open 2016 Oct 31; 6(10):e011774.Google Scholar

Albright, B., de la Torre, L., Skipper, B., et al. Changes in methadone maintenance therapy during and after pregnancy. J Subst Abuse Treat. 2011 Dec; 41(4):347–53.Google Scholar

McCarthy, J. J., Leamon, M. H., Willits, N. H., Salo, R. The effect of methadone dose regimen on neonatal abstinence syndrome. J Addict Med 2015 Mar–Apr; 9(2):105–10.CrossRefGoogle ScholarPubMed

Alto, W. A., O'Connor, A. B. Management of women treated with buprenorphine during pregnancy. Am J Obstet Gynecol 2011 Oct; 205(4):302–8.Google Scholar

Holbrook, A. M., Baxter, J. K., Jones, H. E., et al. Infections and obstetric outcomes in opioid-dependent pregnant women maintained on methadone or buprenorphine. Addiction 2012 Nov; 107(Suppl 1):83–90.Google Scholar

Jansson, L. M., Di Pietro, J. A., Elko, A., et al. Pregnancies exposed to methadone, methadone and other illicit substances, and poly-drugs without methadone: A comparison of fetal neurobehaviors and infant outcomes. Drug Alcohol Depend 2012 May 1; 122(3):213–9.CrossRefGoogle ScholarPubMed

Jansson, L. M., Dipietro, J. A., Velez, M., et al. Maternal methadone dosing schedule and fetal neurobehaviour. J Matern Fetal Neonatal Med 2009 Jan; 22(1):29–35.Google Scholar

Salisbury, A. L., Coyle, M. G., O'Grady, K. E., et al. Fetal assessment before and after dosing with buprenorphine or methadone. Addiction 2012 Nov; 107(Suppl 1):36–44.Google Scholar

Gryczynski, J., Mitchell, S. G., Jaffe, J. H. et al. Retention in methadone and buprenorphine treatment among African Americans. J Subst Abuse Treat 2013; 45(3):287–92.Google Scholar

Bell, J. R., Butler, B., Lawrance, A., et al. Comparing overdose mortality associated with methadone and buprenorphine treatment. Drug Alcohol Depend 2009; 104(1–2):73–7.CrossRefGoogle ScholarPubMed

Jones, H. E., Kaltenbach, K., Heil, S., et al. Neonatal abstinence syndrome following methadone or buprenorphine exposure. N Engl J Med 2010 Dec; 363(24):2320–31.Google Scholar

Jones, H. E., Heil, S. H., Tuten, M., et al. Cigarette smoking in opioid-dependent pregnant women: Neonatal and maternal outcomes. Drug Alcohol Depend Aug 2013; 131(3):271–7.Google Scholar

McNicholas, L. F., Holbrook, A. M., O'Grady, K. E., et al. Effect of hepatitis C virus status on liver enzymes in opioid-dependent pregnant women maintained on opioid-agonist medication. Addiction 2012 Nov; 107(Suppl 1):91–7.Google Scholar

Reece-Stremtan, S., Marinelli, K. A. ABM clinical protocol #21: guidelines for breastfeeding and substance use or substance use disorder, revised 2015. Breastfeed Med 2015 Apr; 10(3):135–41.Google Scholar

Kaltenbach, K., O'Grady, K. E., Heil, S. H., et al. Prenatal exposure to methadone or buprenorphine: Early childhood developmental outcomes. Drug and Alcohol 2018 (in press).Google Scholar

Meyer, M. C., Johnston, A. M., Crocker, A. M., Heil, S. H. Methadone and buprenorphine for opioid dependence during pregnancy: A retrospective cohort study. J Addict Med 2015 Mar–Apr; 9(2):81–6.Google Scholar

Kakko, J., Heilig, M., Sarman, I. Buprenorphine and methadone treatment of opiate dependence during pregnancy: Comparison of fetal growth and neonatal outcomes in two consecutive case series. Drug Alcohol Depend 2008 Jul 1; 96(1–2):69–78.Google Scholar

Jones, H. E., O'Grady, K. E., Johnson, R. E., et al. Management of acute post-partum pain in patients maintained on methadone or buprenorphine during pregnancy. Am J Drug Alcohol Abuse 2009 Jan; 35(3):151–6.Google Scholar

Jones, H. E., Johnson, R. E., Milio, L. Post-cesarean pain management of patients maintained on methadone or buprenorphine. Am J Addict 2006 May–Jun; 15(3);258–9.Google Scholar

Pace, C. A., Kaminetzky, L. B., Winter, M., et al. Postpartum changes in methadone maintenance dose. J Subst Abuse Treat 2014 Sep; 47(3):229–32.Google Scholar

Gaalema, D. E., Heil, S. H., Badger, G. J., et al. Time to initiation of treatment for neonatal abstinence syndrome in neonates exposed in utero to buprenorphine or methadone. Drug Alcohol Depend. 2013 Nov 1; 133(1):266–9.CrossRefGoogle ScholarPubMed

Jones, H. E., Martin, P. R., Heil, S. H., et al. Treatment of opioid-dependent pregnant women: clinical and research issues. Journal of Substance Abuse Treatment. Oct 2008;35(3):245–59.Google Scholar

Joseph, H., Dole, V. P. Methadone patients on probation and parole. Federal probation. Jun 1970;34:42–8.Google Scholar

Dole, V. P., Nyswander, M. A medical treatment for diacetylmorphine (heroin) addiction. A clinical trial with methadone hydrochloride. JAMA. Aug 23 1965;193:646–50.Google Scholar

Blinick, G., Jerez, E., Wallach, R. C. Methadone maintenance, pregnancy, and progeny. JAMA. Jul 30 1973;225(5):477–9.Google Scholar

Treatment CfSA. Medication-Assisted Treatment for Opioid Addiction in Opioid Treatment Programs. Treatment Improvement Protocol (TIP) Series, No. 43. Center for Substance Abuse Treatment. Rockville, MD: Substance Abuse and Mental Health Services Administration (US); 2005.Google Scholar

Hartel, D. M., Schoenbaum, E. E. Methadone Treatment Protects against HIV Infection: Two Decades of Experience in the Bronx, New York City. Public Health Reports (Washington, D.C.: 1974). Jun 1998;113(Suppl 1):107–15.Google Scholar

Treatment CfSA. Clinical Guidelines for the Use of Buprenorphine in the Treatment of Opioid Addiction. Treatment Improvement Protocol (TIP) Series, No. 40. Center for Substance Abuse Treatment. Rockville, MD: Substance Abuse and Mental Health Services Administration (US); 2004.Google Scholar

Jones, H. E., Kaltenbach, K., Heil, S. H., et al. Neonatal abstinence syndrome after methadone or buprenorphine exposure. The New England Journal of Medicine. Dec 9 2010;363(24):2320–31.Google Scholar

ACOG Committee. Opinion No. 524: Opioid abuse, dependence, and addiction in pregnancy. Obstetrics and Gynecology. May 2012;119(5):1070–6.Google Scholar

SAMHSA. Certification of Opioid Treatment Programs (OTPs). 2015; www.samhsa.gov/medication-assisted-treatment/opioid-treatment-programs. Accessed January 6, 2017.Google Scholar

American Society of Addiction Medicine. Nurse Practitioners and Physician Assistants Prescribing Buprenorphine. www.asam.org/quality-practice/practice-resources/nurse-practitioners-and-physician-assistants-prescribing-buprenorphine. Accessed February 25, 2017.Google Scholar

Pond, S. M., Kreek, M. J., Tong, T. G., Raghunath, J., Benowitz, N. L. Altered methadone pharmacokinetics in methadone-maintained pregnant women. The Journal of Pharmacology and Experimental Therapeutics. Apr 1985;233(1):1–6.Google ScholarPubMed

McCarthy, J. J., Leamon, M. H., Willits, N. H., Salo, R. The effect of methadone dose regimen on neonatal abstinence syndrome. Journal of Addiction Medicine. Mar–Apr 2015;9(2):105–10.Google Scholar

Cleary, B. J., Donnelly, J., Strawbridge, J., et al. Methadone dose and neonatal abstinence syndrome – systematic review and meta-analysis. Addiction (Abingdon, England). Dec 2010;105(12):2071–84.Google Scholar

American Academy of Pediatrics Committee on Drugs: The transfer of drugs and other chemicals into human milk. Pediatrics. Jan 1994;93(1):137–50.Google Scholar

Jansson, L. M., Choo, R., Velez, M. L., et al. Methadone maintenance and breastfeeding in the neonatal period. Pediatrics. Jan 2008;121(1):106–14.Google ScholarPubMed

American Academy of Pediatrics Committee on Drugs. Transfer of drugs and other chemicals into human milk. Pediatrics. Sep 2001;108(3):776–89.Google Scholar

McCarthy, J. J. Intrauterine abstinence syndrome (IAS) during buprenorphine inductions and methadone tapers: can we assure the safety of the fetus? The Journal of Maternal-Fetal & Neonatal Medicine: The Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstet. Feb 2012;25(2):109–12.CrossRefGoogle ScholarPubMed

Mannelli, P., Peindl, K. S., Lee, T., Bhatia, K. S., Wu, L. T. Buprenorphine-mediated transition from opioid agonist to antagonist treatment: state of the art and new perspectives. Current Drug Abuse Reviews. Mar 2012;5(1):52–63.Google Scholar

Debelak, K., Morrone, W. R., O'Grady, K. E., Jones, H. E. Buprenorphine + naloxone in the treatment of opioid dependence during pregnancy–initial patient care and outcome data. The American Journal on Addictions. May–Jun 2013;22(3):252–4.Google Scholar

Wiegand, S. L., Stringer, E. M., Stuebe, A. M., et al. Buprenorphine and naloxone compared with methadone treatment in pregnancy. Obstetrics and Gynecology. Feb 2015;125(2):363–8.Google Scholar

Rosenthal, R. N., Lofwall, M. R., Kim, S., et al. Effect of buprenorphine implants on illicit opioid use among abstinent adults with opioid dependence treated with sublingual buprenorphine: a randomized clinical trial. JAMA. Jul 19 2016;316(3):282–90.Google Scholar

Sigmon, S. C., Bigelow, G. E. Food and Drug Administration approval of sustained-release buprenorphine for treatment of opioid dependence: realizing its potential. Addiction (Abingdon, England). Mar 2017;112(3):386–7.Google Scholar

Jones, H. E., Chisolm, M. S., Jansson, L. M., Terplan, M. Naltrexone in the treatment of opioid-dependent pregnant women: the case for a considered and measured approach to research. Addiction (Abingdon, England). Feb 2013;108(2):233–47.Google Scholar

Saia, K. A., Schiff, D., Wachman, E. M., et al. Caring for pregnant women with opioid use disorder in the USA: expanding and improving treatment. Current Obstetrics and Gynecology Reports. 2016;5:257–63.Google Scholar

Jones, H. E. Acceptance of naltrexone by pregnant women enrolled in comprehensive drug addiction treatment: an initial survey. The American Journal on Addictions. May–Jun 2012;21(3):199–201.Google Scholar

Jones, H. E., O'Grady, K. E., Malfi, D., Tuten, M. Methadone maintenance vs. methadone taper during pregnancy: maternal and neonatal outcomes. The American Journal on Addictions. Sep–Oct 2008;17(5):372–86.Google Scholar

Bell, J., Towers, C. V., Hennessy, M. D., et al. Detoxification from opiate drugs during pregnancy. American Journal of Obstetrics and Gynecology. Sep 2016;215(3):374. e371–76.Google Scholar

Rementeria, J. L., Nunag, N. N. Narcotic withdrawal in pregnancy: stillbirth incidence with a case report. American Journal of Obstetrics and Gynecology. Aug 15 1973;116(8):1152–6.Google Scholar

Zuspan, F. P., Gumpel, J. A., Mejia-Zelaya, A., Madden, J., Davis, R. Fetal stress from methadone withdrawal. American Journal of Obstetrics and Gynecology. May 1 1975;122(1):43–6.Google Scholar

Luty, J., Nikolaou, V., Bearn, J. Is opiate detoxification unsafe in pregnancy? Journal of Substance Abuse Treatment. Jun 2003;24(4):363–7.Google Scholar

Welle-Strand, G. K., Skurtveit, S., Tanum, L., et al. Tapering from methadone or buprenorphine during pregnancy: maternal and neonatal outcomes in Norway 1996–2009. European Addiction Research. 2015;21(5):253–61.Google Scholar

Alto, W. A., O'Connor, A. B. Management of women treated with buprenorphine during pregnancy. American Journal of Obstetrics and Gynecology. Oct 2011;205(4):302–8.Google Scholar

Hudak, M. L., Tan, R. C. Neonatal drug withdrawal. Pediatrics. Feb 2012;129(2):e540–60.Google Scholar

Holbrook, A. M., Jones, H. E., Heil, S. H., et al. Induction of pregnant women onto opioid-agonist maintenance medication: an analysis of withdrawal symptoms and study retention. Drug and Alcohol Dependence. Sep 1 2013;132(1–2):329–34.Google Scholar

Srivastava, A., Kahan, M. Methadone induction doses: are our current practices safe? Journal of Addictive Diseases. 2006;25(3):5–13.Google Scholar

McCance-Katz, E. F., Sullivan, L. E., Nallani, S. Drug interactions of clinical importance among the opioids, methadone and buprenorphine, and other frequently prescribed medications: a review. The American Journal on Addictions. Jan–Feb 2010;19(1):4–16.Google Scholar

Chou, R., Cruciani, R. A., Fiellin, D. A., et al. Methadone safety: a clinical practice guideline from the American Pain Society and College on Problems of Drug Dependence, in collaboration with the Heart Rhythm Society. The Journal of Pain: Official Journal of the American Pain Society. Apr 2014;15(4):321–37.Google Scholar

Boba, A. Management of acute alcoholic intoxication. The American Journal of Emergency Medicine 1999;17:431.Google Scholar

Asplund, C. A., Aaronson, J. W., Aaronson, H. E. 3 Regimens for alcohol withdrawal and detoxification. Journal of Family Practice 2004 July;53(7):545–54.Google Scholar

Kosten, T. R., O'Connor, P. G. Management of drug and alcohol withdrawal. The New England Journal of Medicine 2003;348:1786–96.Google Scholar

Weinbroum, A. A., Flaishon, R., Sorkine, P., Szold, O., Rudick, V. A risk–benefit assessment of flumazenil in the management of benzodiazepine overdose. Drug Safety 1997;17:181–95.Google Scholar

Kawasaki, S. S., Jacapraro, J. S., Rastegar, D. A. Safety and effectiveness of a fixed-dose phenobarbital protocol for inpatient benzodiazepine detoxification. Journal of Substance Abuse Treatment 2012;43:331–4.Google Scholar

Phillips, K., Luk, A., Soor, G. S., et al. Cocaine cardiotoxicity: a review of the pathophysiology, pathology, and treatment options. American Journal of Cardiovascular Drugs: Drugs, Devices, and Other Interventions 2009;9:177–96.Google Scholar

Salisbury, A. L., Coyle, M. G., O'Grady, K. E., et al. Fetal assessment before and after dosing with buprenorphine or methadone. Addiction 2012;107(Suppl 1):36–44.CrossRefGoogle ScholarPubMed

Preston, K. L., Bigelow, G. E., Liebson, I. A. Antagonist effects of nalbuphine in opioid-dependent human volunteers. The Journal of Pharmacology and Experimental Therapeutics 1989;248:929–37.Google Scholar

Preston, K. L., Bigelow, G. E., Liebson, I. A. Butorphanol-precipitated withdrawal in opioid-dependent human volunteers. The Journal of Pharmacology and Experimental Therapeutics 1988;246:441–8.Google Scholar

Salsitz, E. A., Holden, C. C., Tross, S., Nugent, A. Transitioning stable methadone maintenance patients to buprenorphine maintenance. Journal of Addiction Medicine 2010;4:88–92.Google Scholar

Eyler, E. C. Chronic and acute pain and pain management for patients in methadone maintenance treatment. The American Journal on Addictions 2013;22:75–83.Google Scholar

Compton, P., Canamar, C. P., Hillhouse, M., Ling, W. Hyperalgesia in heroin dependent patients and the effects of opioid substitution therapy. The Journal of Pain: Official Journal of the American Pain Society 2012;13:401–9.Google Scholar

Meyer, M., Wagner, K., Benvenuto, A., Plante, D., Howard, D. Intrapartum and postpartum analgesia for women maintained on methadone during pregnancy. Obstetrics and Gynecology 2007;110:261–6.Google Scholar

Meyer, M., Paranya, G., Keefer Norris, A., Howard, D. Intrapartum and postpartum analgesia for women maintained on buprenorphine during pregnancy. European Journal of Pain 2010;14:939–43.Google Scholar

Jones, L., Othman, M., Dowswell, T., et al. Pain management for women in labour: an overview of systematic reviews. The Cochrane Database of Systematic Reviews 2012; (3): Art. No. CD009234.Google Scholar

Hoflich, A. S., Langer, M., Jagsch, R., et al. Peripartum pain management in opioid dependent women. European Journal of Pain 2012;16:574–84.Google Scholar

Gritsenko, K., Khelemsky, Y., Kaye, A. D., Vadivelu, N., Urman, R. D. Multimodal therapy in perioperative analgesia. Best Practice & Research. Clinical Anaesthesiology 2014;28:59–79.Google Scholar

Behdad, S., Hajiesmaeili, M. R., Abbasi, H. R., et al. Analgesic effects of intravenous ketamine during spinal aesthesia in pregnant women undergone caesarean section: a randomized clinical trial. Anesthesiology and Pain Medicine 2013;3:230–3.Google Scholar

Gharaei, B., Jafari, A., Aghamohammadi, H., et al. Opioid-sparing effect of preemptive bolus low-dose ketamine for moderate sedation in opioid abusers undergoing extracorporeal shock wave lithotripsy: a randomized clinical trial. Anesthesia and Analgesia 2013;116:75–80.Google Scholar

Mishriky, B. M., George, R. B., Habib, A. S. Transversus abdominis plane block for analgesia after Cesarean delivery: a systematic review and meta-analysis. Canadian Journal of Anaesthesia – Journal Canadien D'anesthesie 2012;59:766–78.Google Scholar

Jones, H. E., O'Grady, K., Dahne, J., et al. Management of acute postpartum pain in patients maintained on methadone or buprenorphine during pregnancy. The American Journal of Drug and Alcohol Abuse 2009;35:151–6.Google Scholar

Bartels, K., Mayes, L. M., Dingmann, C., et al. Opioid use and storage patterns by patients after hospital discharge following surgery. PLoS One 2016;11:e0147972.Google Scholar